共 68 条
[1]
Lee E(2020)Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea BMC Infect Dis 20 132-157
[2]
Kim CH(2017)Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children Korean J Pediatr 60 151-1799
[3]
Lee YJ(2021)Cases of macrolide-resistant Mycoplasma pneumoniae pneumonia-associated pulmonary thromboembolism Pediatr Pulmonol 56 1796-34
[4]
Lee E(2018)Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children Expert Rev Anti Infect Ther 16 23-387
[5]
Cho HJ(2016)Classification of extrapulmonary manifestations due to mycoplasma pneumoniae infection on the basis of possible pathogenesis Front Microbiol 7 23-974
[6]
Hong SJ(2018)Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis Curr Opin Rheumatol 30 380-273
[7]
Lee J(2020)Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children Pediatr Pulmonol 55 968-1475
[8]
Sung H(2020)Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia Respir Res 21 171-183
[9]
Yu J(2016)The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children Sci Rep 6 39929-565
[10]
Kim YS(2014)Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level J Infect Chemother 20 270-217